AstraZeneca Acquires Acerta Pharma for $4,000,000,000

Feed Type
Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=9ee5679f-bb37-4b74-9540-f9f1650bb13d
Date
12/17/2015
Company Name
Acerta Pharma
Mailing Address
1509 Industrial Rd. San Carlos, CA 94070 USA
Company Description
Acerta Pharma B.V. offers drug discovery and development services for oncology and autoimmune diseases. The company is based in Oss, the Netherlands.
Website
http://www.acerta-pharma.com
Transaction Type
M&A
Transaction Amount
$4,000,000,000
Transaction Round
Proceeds Purposes
M&A Terms
AstraZeneca is to buy 55 percent of privately held biotech firm Acerta Pharma for $4 billion to give it access to a new kind of blood cancer drug, boosting its long-term growth at the cost of a near-term hit to earnings.